Тhе features of a personalized approach to the treatment of cardiovascular diseases during pregnancy


Keywords: pregnancy, cardiovascular pathology, treatment, gestational endotheliopathy, heart failure, antihypertensive drugs, antithrombotic drugs.

Abstract

Annotation. For the cases of cardiovascular pathology during pregnancy include hypertensive disorders, hypercholesterolemia, myocardial infarction, cardiomyopathy, arrhythmias, valve disease, thromboembolic diseases, aortic disease and cerebrovascular pathology. Cardiovascular disease (CVD) is the leading cause of death from pregnancy in the world. Raising maternal age and comorbid diseases contribute to increased maternal mortality, also. When searching for literature, we used Medline systems from PubMed (2011). The search was adapted for Embase (2015 - 2021) and Scopus (2017 - 2021). Inclusion criteria were as follows: the impact of diseases of the cardiovascular system on pregnancy; the impact of pregnancy on the course of cardiovascular disease; features of diagnosis and prevention of women with CVD at the stage of preconception and during pregnancy; safety of drugs for the treatment of cardiovascular pathology during pregnancy; choice of drugs to prevent perinatal pathology in women with CVD; features of antenatal observation in CVD. We excluded from the study: references to 2011 (more than 10 years); not English; all methods that were not directly related to the pathology of the cardiovascular system during pregnancy; concomitant diseases that can lead to aggravation of pregnancy; animal studies. As a result, 76 studies were identified that were subject to final inclusion in the systematic review. Analysis of the identified literature sources showed that the preconception reproductive strategy to be developed by a multidisciplinary cardio-obstetric team is becoming important for women with a history of cardiovascular disease or for those with a history of familial preeclampsia. Cardio-obstetrics has become as an important multidisciplinary industry that requires a team approach to optimizing the clinical management of cardiovascular disease during pregnancy. Timely involvement of the cardio-obstetric group is crucial to prevent maternal morbidity and mortality during pregnancy and 1 year after delivery. A general understanding of the importance of the impact of cardiovascular disease on pregnancy and the impact of pregnancy on existing CVD should be a basic area of expertise for family medicine professionals, cardiologists, obstetricians and gynecologists. The given scientific and clinical review of sources of evidence-based medicine contains certain features of predictor diagnosis, prevention and treatment of manifested forms of cardiovascular diseases during pregnancy.

References

[1] ACOG (2019). ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstet Gynecol., 133(1), e78-e89. Doi: 10.1097/AOG.0000000000003013

[2] Alfonso, F., Paulo, M., & Dutary, J. (2012). Endovascular imaging of angiographically invisible spontaneous coronary artery dissection. JACC Cardiovasc Interv., 5(4), 452-453. Doi: 10.1016/j.jcin.2012.01.016

[3] Alshawabkeh, L., Economy, K. E., & Valente, A. M. (2016). Anticoagulation during pregnancy: evolving strategies with a focus on mechanical valves. J Am Coll Cardiol., 68(16), 1804-1813. Doi:10.1016/j.jacc.2016.06.076

[4] American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins Obstetrics. (2019). ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol., 133(1), e26-e50. Doi: 10.1097/AOG.0000000000003020

[5] American College of Obstetricians and Gynecologists’ Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics. (2019). ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease. Obstet Gynecol., 133(5), e320-e356. Doi: 10.1097/AOG.0000000000003243

[6] Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey Jr, D. E., Ganiats, T. G., Holmes Jr, D. R., … & Zieman, S. J. (2014). AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol., 64(24), e139-e228. doi: 10.1016/j.jacc.2014.09.017

[7] Arany, Z., & Elkayam, U. (2016). Peripartum cardiomyopathy. Circulation, 133, 1397-1409. Doi: 10.1161/CIRCULATIONAHA.115.020491

[8] Belkaniya, G. S., Dilenyan, L. R., Konkov, D. G., Wsol, A., Martusevich, A. K., & Puchalska, L. G. (2021). An anthropogenic model of cardiovascular system adaptation to the Earth’s gravity as the conceptual basis of pathological anthropology. J Physiol Anthropol., 40(9). DOI: https://doi.org/10.1186/s40101-021-00260-2

[9] Belkaniya, G. S., Kon’kov, D. G., Dilenyan, L. R., Razzhivin, A. P., Pukhalskaya, L. G., Bocharin, I. V., ... & Korepanov, S. K. (2017). Новый взгляд на кровообращение у беременных – антропофизиологическая диагностика гемодинамического обеспечения беременности [A new perspective on the circulation of pregnant women – antropotehnicheskaya diagnosis of hemodynamic ensure pregnancy]. Современные проблемы науки и образования – Modern problems of science and education, 5. https://science-education.ru/ru/article/view?id=26872

[10] Boodhwani, M., Andelfinger, G., Leipsic, J., Lindsay, T., McMurtry, M. S., Therrien, J., & Siu, S. C. (2014). Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. Can J Cardiol., 30(6), 577-589. Doi:10.1016/j.cjca.2014.02.018

[11] Brown, H. L., Warner, J. J., Gianos, E., Gulati, M., Hill, A. J., Hollier, L. M., … & Wenger, N. K. (2018). Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation, 137(24), e843-e852. doi: 10.1161/CIR.0000000000000582

[12] Building, U. S. (2018). Capacity to review and prevent maternal deaths. Report from nine maternal mortality review committees. http://reviewtoaction.org/Report_from_Nine_MMRCs

[13] Cauldwell, M., Rudd, A., & Nelson-Piercy, C. (2018). Management of stroke and pregnancy. Eur Stroke J., 3, 227-236. Doi: 10.1177/2396987318769547

[14] Chapman, A. B., Abraham, W. T., Zamudio, S., Coffin, C., Coffin, C., Merouani, A., Young, D., … & Schrier, R. W. (1998). Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int., 54(6)б, 2056-63. Doi: 10.1046/j.1523-1755.1998.00217

[15] Ferranti, E. P., Jones, E. J., & Hernandez, T. L. (2016). Pregnancy reveals evolving risk for cardiometabolic disease in women. JOGNN – J Obstet Gynecol Neonatal Nurs., 45(3), 413-425. Doi: 10.1016/j.jogn.2016.02.004

[16] Fischer, T., Schobel, H. P., Frank, H., Andreae, M., Schneider, K. T. M., & Heusser, K. (2004). Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia. Eur J Clin Invest., 34(6), 443-8. Doi: 10.1111/j.1365-2362.2004.01350.x

[17] Fujime, M., Tomimatsu, T., Okaue, Y., Koyama, S., Kanagawa, T., & Kimura, T. (2012). Central aortic blood pressure and augmentation index during normal pregnancy. Hypertens Res., 35(6), 633-8. Doi: 10.1038/hr.2012.1

[18] Gennari-Moser, C., Khankin, E. V., Schüller, S., Escher, G., Frey, B. M., Portmann, C.-B., … & Mohaupt, M. G. (2011). Regulation of placental growth by aldosterone and cortisol. Endocrinology, 1, 263-71. Doi: 10.1210/en.2010-0525

[19] Georgiopoulos, G., Tsiaxris, D., Kordalis, A., Kontogiannis, C., Spartalis, M., Pietri, P., … & Stefanadis, C. (2019). Pharmacotherapeutic strategies for atrial fibrillation in pregnancy. Expert Opin Pharmacother, 20(13), 1625-1636. Doi: 10.1080/14656566.2019.1621290

[20] Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T. … & Yeboah, J. (2019). Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), e1082-e1143. Doi: 10.1161/CIR.0000000000000625

[21] Hilfiker-Kleiner, D., Haghikia, A., Berliner, D., Vogel-Claussen, J., Schwab, J., Franke, A., … & Bauersachs, J. (2017). Bromocriptine for the treatment of peripartum cardiomyopathy: a multicenter randomized study. Eur Heart J., 38(35), 2671-2679. Doi: 10.1093/eurheartj/ehx355

[22] Jacob, R., & Khan, M. (2018). Cardiac Biomarkers: What Is and What Can Be.. Indian J Cardiovasc Dis Women WINCARS, 3(4), 240-244. Doi:10.1055/s-0039-1679104

[23] Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Jones, P. H., Kris-Etherton, P., Sikand, G., … & Underberg, J. A. (2015). National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol., 9(6), 1-122.e1. doi: 10.1016/j.jacl.2015.09.002

[24] Jarvis, S. S., Shibata, S., Bivens, T. B., Okada, Y., Casey, B. M., Levine, B. D., & Fu, Q. (2012). Sympathetic activation during early pregnancy in humans. J Physiol., 590(15), 3535-43. Doi: 10.1113/jphysiol.2012.228262

[25] Konkov, D. G., Belkania, G. S., & Puchalska, L. G. (2018). The modern hemodynamic features of predictive diagnosis of preeclampsia. In: The abstract book of the 18th World Congress of the Gynecological Endocrinology, 7-10 March 2018. Florence (Italy).

[26] Kotit, S., & Yacoub, M. (2021). Cardiovascular adverse events in pregnancy: A global perspective. Glob Cardiol Sci Pract., 2021(1), e202105. Doi:10.21542/gcsp.2021.5

[27] Ladhani, N. N. N., Swartz, R. H., Foley, N., Nerenberg, K., Smith, E. E., Gubitz, G., … & Lindsay, M. P. (2018). Canadian Stroke Best Practice Consensus Statement: Acute Stroke Management during pregnancy. Int J Stroke, 13(7), 743-758. Doi:10.1177/1747493018786617

[28] Lameijer, H., van Slooten, Y. J., Jongbloed, M. R. M., Oudijk, M. A., Kampman, M. A. M., van Dijk, A. P., … & Pieper, P. G. (2018). Biological versus mechanical heart valve prosthesis during pregnancy in women with congenital heart disease. Int J Cardiol., 268, 106-112. Doi:10.1016/j.ijcard.2018.05.038

[29] Leffert, L., Butwick, A., Carvalho, B., Arendt, K., Bates, S. M., Friedman, A., … & Toledo, P. (2018). SOAP VTE Taskforce. The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg., 126(3), 928-944. Doi: 10.1213/ANE.0000000000002530

[30] Lumbers, E. R., & Pringle, K. G. (2014). Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol., 306(2), R91-101. Doi: 10.1152/ajpregu.00034.2013

[31] Macdorman, M. F., Declercq, E., Cabral, H., & Morton, C. (2016). Recent increases in the U.S. maternal mortality rate: disentangling trends from measurement issues. Obstet Gynecol., 128(3), 447-455. doi: 10.1097/AOG.0000000000001556

[32] Mahendru, A. A., Everett, T. R., Wilkinson, I. B., Lees, C. C., McEniery, C. M. (2014). A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens, 32(4), 849-56. Doi: 10.1097/HJH.0000000000000090

[33] McDermott, M., Miller, E. C., Rundek, T., Hurn, P. D., Bushnell, C. D. (2018). Preeclampsia: association with posterior reversible encephalopathy syndrome and stroke. Stroke, 49(3), 524-530. Doi: 10.1161/STROKEAHA.117.018416

[34] McNamara, D. M., Elkayam, U., Alharethi, R., Damp, J., Hsich, E., Ewald, G., … & Fett, J. D. (2015). IPAC Investigators. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol., 66(8), 905-914. Doi: 10.1016/j.jacc.2015.06.1309

[35] Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., … & Volgman, A. S. (2020). Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association. Circulation, 141(23), e884-e903. Doi: 10.1161/CIR.0000000000000772

[36] Nair, M., Nelson-Piercy, C., & Knight, M. (2017). Indirect maternal deaths: UK and global perspectives. Obstet Med., 10(1), 10-15. Doi: 10.1177/1753495X16689444

[37] Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin III, J. P., Guyton, R. A., ... & Thomas, J. D. (2014). 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(23), e521-e643. doi: 10.1161/CIR.0000000000000031

[38] O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey Jr, D. E., Chung, M. K., de Lemos, J. A., … & Yancy, C. W. (2013). ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127(4), e362-e425. Doi: 10.1161/CIR.0b013e3182742cf6

[39] Owens, A. T. (2017). Pregnancy in hypertrophic cardiomyopathy. Eur Heart J., 38(35), 2691-2692. Doi: 10.1093/eurheartj/ehx304

[40] Poppas, A., Shroff, S. G., Korcarz, C. E., Hibbard, J. U., Berger, D. S., Lindheimer, M. D., & Lang, R. M. (1997). Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation., 95(10), 2407-15. Doi: 10.1161/01.cir.95.10.2407

[41] Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., … & Van Veldhuisen, D. J. (2015). 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J., 36(41), 2793-2867. Doi: 10.1093/eurheartj/ehv316

[42] Rana, S., Lemoine, E., Granger, J. P., & Karumanchi, S. A. (2019). Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res., 124(7), 1094-1112. Doi: 10.1161/CIRCRESAHA.118.313276

[43] Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., … & Warnes, C. A. (2018). 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J., 39(34), 3165-3241. Doi: 10.1093/eurheartj/ehy340

[44] Sanghavi, M., & Rutherford, J. D. (2014). Cardiovascular physiology of pregnancy. Circulation, 130(12), 1003-8. Doi: 10.1161/CIRCULATIONAHA.114.009029

[45] Saw, J., Humphries, K., Aymong, E., Sedlak, T., Prakash, R., Starovoytov, A., & Mancini, G. B. J. (2017). Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence. J Am Coll Cardiol., 70(9), 1148-1158. Doi: 10.1016/j.jacc.2017.06.053

[46] Silversides, C. K., Grewal, J., Mason, J., Sermer, M., Kiess, M., Rychel, V., … & Siu, S. C. (2018). Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study. J Am Coll Cardiol., 71(21), 2419-2430. Doi:10.1016/j.jacc.2018.02.07

[47] Smilowitz, N. R., Gupta, N., Guo, Y., Zhong, J., Weinberg, C. R., Reynolds, H. R., & Bangalore, S. (2018). Acute myocardial infarction during pregnancy and the puerperium in the United States. Mayo Clin Proc., 93(10), 1404-1414. Doi: 10.1016/j.mayocp.2018.04.019

[48] Storm, F., Agampodi, S., Eddleston, M., Sørensen, J. B., Konradsen, F., & Rheinländer, T. (2014). Indirect causes of maternal death. Lancet Glob Heal., 2(10), e566. Doi: 10.1016/S2214-109X(14)70297-9

[49] Svensson, L. G., Adams, D. H., Bonow, R. O., Kouchoukos, N. T., Miller, D. C., O'Gara, P. T., … & Williams, M. R. (2013). Aortic valve and ascending aorta guidelines for management and quality measures: executive summary. Ann Thorac Surg., 95(4), 1491-1505. Doi:10.1016/j.athoracsur.2012.12.027

[50] Swartz, R. H., Cayley, M. L., Foley, N., Ladhani, N. N. N., Leffert, L., Bushnell, C., … & Lindsay, M. P. (2017). The incidence of pregnancy-related stroke: A systematic review and meta-analysis. Int J Stroke, 12(7), 687-697. Doi:10.1177/1747493017723271

[51] Trappe, H. J. (2006). Acute therapy of maternal and fetal arrhythmias during pregnancy. J Intensive Care Med., 21(5), 305-315. Doi: 10.1177/0885066606291433

[52] Treadwell, S. D., Thanvi, B., & Robinson, T. G. (2008). Stroke in pregnancy and the puerperium. Postgrad Med J., 84(991), 238-245. Doi:10.1136/pgmj.2007.066167

[53] Vaidya, V. R., Arora, S., Patel, N., Badheka, A. O., Patel, N., Agnihotri, K., … & Deshmukh, A. J. (2017). Burden of arrhythmia in pregnancy. Circulation, 135(6), 619-621. Doi: 10.1161/CIRCULATIONAHA.116.026681.56

[54] van Hagen, I. M., Boersma, E., Johnson, M. R., Thorne, S. A., Parsonage, W. A., S ubías, P. E., … & Roos-Hesselind, J. W. (2016). ROPAC investigators and EORP team. Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology. Eur J Heart Fail, 18(5), 523-33. Doi: 10.1002/ejhf.501

[55] van Hagen, I. M., Thorne, S. A., Taha, N., Youssef, G., Elnagar, A., Gabriel, H., … & Roos, J. W. (2018). Pregnancy outcomes in women with rheumatic mitral valve disease: results from the Registry of Pregnancy and Cardiac Disease. Circulation, 137(8), 806-816. Doi: 10.1161/CIRCULATIONAHA.117.032561

[56] Webster, K., Fishburn, S., Maresh, M., Findlay, S. C., & Chappell, L. C. (2019). Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ, 366, l5119. Doi: 10.1136/bmj.l5119

[57] WHO. (2019). Trends in maternal mortality: 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization.

[58] WHO. (2021). Maternal mortality. https://www.who.int/news-room/fact-sheets/detail/maternal-mortality

[59] Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., Zaman, A., … & Mamas, M. A. (2017). Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes, 10(2), e003497. Doi: 10.1161/CIRCOUTCOMES.116.003497.17

[60] Zhu, D., Zhao, P., Lv, N., Li, Q., Fang, Y., Li, Z., … & Huang, Q. (2018). Rupture Risk of Cerebral Arteriovenous Malformations During Pregnancy and Puerperium: A Single-Center Experience and Pooled Data Analysis. World Neurosurg., 111, e308-e315. Doi:10.1016/j.wneu.2017.12.056
Published
2021-09-23
How to Cite
Konkov, D. G., Bulavenko, O. V., Adamchuk, N. V., & KosianenkoS. М. (2021). Тhе features of a personalized approach to the treatment of cardiovascular diseases during pregnancy. Reports of Vinnytsia National Medical University, 25(3), 498-509. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2021-25(3)-27